BRPI0520049B8 - composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma - Google Patents
composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesmaInfo
- Publication number
- BRPI0520049B8 BRPI0520049B8 BRPI0520049A BRPI0520049A BRPI0520049B8 BR PI0520049 B8 BRPI0520049 B8 BR PI0520049B8 BR PI0520049 A BRPI0520049 A BR PI0520049A BR PI0520049 A BRPI0520049 A BR PI0520049A BR PI0520049 B8 BRPI0520049 B8 BR PI0520049B8
- Authority
- BR
- Brazil
- Prior art keywords
- osteoblast
- semi
- bone
- fibrin
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR102005-0050450 | 2005-06-13 | ||
KR1020050050450A KR100702250B1 (ko) | 2005-06-13 | 2005-06-13 | 피브린 혼합형 골절 유합용 반고형성 뼈세포 조성물 및이의 제조방법 |
PCT/KR2005/002531 WO2006135126A1 (en) | 2005-06-13 | 2005-08-03 | Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0520049A2 BRPI0520049A2 (pt) | 2009-04-14 |
BRPI0520049B1 BRPI0520049B1 (pt) | 2020-12-22 |
BRPI0520049B8 true BRPI0520049B8 (pt) | 2021-05-25 |
Family
ID=37532459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0520049A BRPI0520049B8 (pt) | 2005-06-13 | 2005-08-03 | composição semi-sólida de osteoblastos contendo fibrina para a união óssea e método para o preparo da mesma |
Country Status (19)
Country | Link |
---|---|
US (1) | US20080213229A1 (pt) |
EP (1) | EP1890713B1 (pt) |
JP (1) | JP2008532723A (pt) |
KR (1) | KR100702250B1 (pt) |
CN (1) | CN101247814A (pt) |
AT (1) | ATE503486T1 (pt) |
BR (1) | BRPI0520049B8 (pt) |
CY (1) | CY1111795T1 (pt) |
DE (1) | DE602005027260D1 (pt) |
DK (1) | DK1890713T3 (pt) |
ES (1) | ES2362430T3 (pt) |
HR (1) | HRP20110391T1 (pt) |
MX (1) | MX2007012041A (pt) |
PL (1) | PL1890713T3 (pt) |
PT (1) | PT1890713E (pt) |
RS (1) | RS51724B (pt) |
SG (1) | SG162750A1 (pt) |
SI (1) | SI1890713T1 (pt) |
WO (1) | WO2006135126A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101037002B1 (ko) * | 2008-09-30 | 2011-05-25 | 세원셀론텍(주) | 연골세포 조기배양을 위한 연골세포 특이적 배양방법 |
KR100932945B1 (ko) | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
KR100932948B1 (ko) * | 2009-01-16 | 2009-12-21 | 원광대학교산학협력단 | Bmp-2를 함유하는 골 분말과 피브린 글루로 이루어진 고형의 스캐폴드 |
WO2020161747A1 (en) * | 2019-02-08 | 2020-08-13 | Regrow Biosciences Private Limited | Osteoblast cell-mixture, and implementations thereof |
CN113827778B (zh) * | 2021-11-03 | 2022-10-21 | 浙江赛灵特医药科技有限公司 | 一种注射式骨修复剂及其应用 |
CN113975468A (zh) * | 2021-11-11 | 2022-01-28 | 成都中科娥皇健康咨询有限公司 | 一种骨膜组织老化修复剂及其制备工艺 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972703A (en) * | 1994-08-12 | 1999-10-26 | The Regents Of The University Of Michigan | Bone precursor cells: compositions and methods |
US6599515B1 (en) * | 1995-01-16 | 2003-07-29 | Baxter International Inc. | Fibrin porous structure |
DE19949290A1 (de) * | 1999-10-12 | 2001-04-26 | Albrecht Bettermann | Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin |
DE19956503A1 (de) * | 1999-11-24 | 2001-06-21 | Universitaetsklinikum Freiburg | Spritzbares Knochenersatzmaterial |
JP2003525696A (ja) * | 2000-03-03 | 2003-09-02 | スミス アンド ネフュー インコーポレーテッド | 造形粒子および骨欠損用組成物および粒子を作る方法 |
IL144446A0 (en) * | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
KR100522457B1 (ko) * | 2002-04-13 | 2005-10-18 | 주식회사 셀론텍 | 뼈세포의 배양방법 및 조성물 |
EP1635887A2 (en) * | 2003-06-12 | 2006-03-22 | Interface Biotech A/S | A method for cell implantation |
US7316822B2 (en) * | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
-
2005
- 2005-06-13 KR KR1020050050450A patent/KR100702250B1/ko active IP Right Grant
- 2005-08-03 SI SI200531313T patent/SI1890713T1/sl unknown
- 2005-08-03 US US11/885,943 patent/US20080213229A1/en not_active Abandoned
- 2005-08-03 ES ES05774219T patent/ES2362430T3/es active Active
- 2005-08-03 RS RS20110212A patent/RS51724B/en unknown
- 2005-08-03 PT PT05774219T patent/PT1890713E/pt unknown
- 2005-08-03 DK DK05774219.9T patent/DK1890713T3/da active
- 2005-08-03 JP JP2008502891A patent/JP2008532723A/ja active Pending
- 2005-08-03 SG SG201003922-0A patent/SG162750A1/en unknown
- 2005-08-03 PL PL05774219T patent/PL1890713T3/pl unknown
- 2005-08-03 BR BRPI0520049A patent/BRPI0520049B8/pt not_active IP Right Cessation
- 2005-08-03 CN CNA2005800492946A patent/CN101247814A/zh active Pending
- 2005-08-03 AT AT05774219T patent/ATE503486T1/de active
- 2005-08-03 MX MX2007012041A patent/MX2007012041A/es active IP Right Grant
- 2005-08-03 EP EP05774219A patent/EP1890713B1/en active Active
- 2005-08-03 WO PCT/KR2005/002531 patent/WO2006135126A1/en active Application Filing
- 2005-08-03 DE DE602005027260T patent/DE602005027260D1/de active Active
-
2011
- 2011-05-24 HR HR20110391T patent/HRP20110391T1/hr unknown
- 2011-06-28 CY CY20111100616T patent/CY1111795T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE602005027260D1 (de) | 2011-05-12 |
BRPI0520049B1 (pt) | 2020-12-22 |
WO2006135126A1 (en) | 2006-12-21 |
KR20060129795A (ko) | 2006-12-18 |
EP1890713A4 (en) | 2009-07-08 |
PT1890713E (pt) | 2011-06-09 |
BRPI0520049A2 (pt) | 2009-04-14 |
SG162750A1 (en) | 2010-07-29 |
KR100702250B1 (ko) | 2007-04-03 |
EP1890713B1 (en) | 2011-03-30 |
US20080213229A1 (en) | 2008-09-04 |
JP2008532723A (ja) | 2008-08-21 |
CN101247814A (zh) | 2008-08-20 |
EP1890713A1 (en) | 2008-02-27 |
MX2007012041A (es) | 2008-03-10 |
ATE503486T1 (de) | 2011-04-15 |
SI1890713T1 (sl) | 2011-07-29 |
DK1890713T3 (da) | 2011-06-27 |
CY1111795T1 (el) | 2015-10-07 |
RS51724B (en) | 2011-10-31 |
PL1890713T3 (pl) | 2011-09-30 |
HRP20110391T1 (hr) | 2011-06-30 |
ES2362430T3 (es) | 2011-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Swanson et al. | Macropore design of tissue engineering scaffolds regulates mesenchymal stem cell differentiation fate | |
Fennema et al. | Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: a comparative study | |
Ahmed et al. | Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute | |
Mishra et al. | Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation | |
Nourissat et al. | Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model | |
Filardo et al. | Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics | |
Guo et al. | Cell‐free strategies for repair and regeneration of meniscus injuries through the recruitment of endogenous stem/progenitor cells | |
CY1111795T1 (el) | Συνθεση οστεοβλαστη ημιστερεοποιημενης αναμεμιγμενης φιμπρινης για συγκολληση καταγματος οστου και η μεθοδος παρασκευης αυτης | |
Hashemi et al. | The role of human adult peripheral and umbilical cord blood platelet-rich plasma on proliferation and migration of human skin fibroblasts | |
Von Wilmowsky et al. | Reconstruction of a mandibular defect with autogenous, autoclaved bone grafts and tissue engineering: an in vivo pilot study | |
Tschon et al. | Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis | |
Yin et al. | The effects of a pulsed electromagnetic field on the proliferation and osteogenic differentiation of human adipose-derived stem cells | |
Montes-Medina et al. | Effect of bone marrow stromal cells in combination with biomaterials in early phases of distraction osteogenesis: An experimental study in a rabbit femur model | |
Neubauer et al. | The Effect of Blood‐Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose‐Derived Mesenchymal Stem Cells Originated from Three Different Locations | |
Wei et al. | The critical role of Hedgehog-responsive mesenchymal progenitors in meniscus development and injury repair | |
Xie et al. | Effects of PRP and LyPRP on osteogenic differentiation of MSCs | |
Al-Qadhi et al. | The gingiva from the tissue surrounding the bone to the tissue regenerating the bone: a systematic review of the osteogenic capacity of gingival mesenchymal stem cells in preclinical studies | |
Pitkänen et al. | Characterisation and in vitro and in vivo evaluation of supercritical-CO2-foamed β-TCP/PLCL composites for bone applications | |
Chen et al. | Synergetic effects of hBMSCs and hPCs in osteogenic differentiation and their capacity in the repair of critical-sized femoral condyle defects | |
Gui et al. | Isolation and characterization of meniscus derived stem cells from rabbit as a possible treatment for damaged meniscus | |
Zhong et al. | In vivo ossification of a scaffold combining β‑tricalcium phosphate and platelet‑rich plasma | |
Pitkänen | In vitro and in vivo osteogenesis and vasculogenesis in synthetic bone grafts | |
MY136958A (en) | Semi-solid osteoblast composition containing fibrin for bone union and method preparing the same | |
Kamal et al. | Comparison of cultured mesenchymal stem cells derived from bone marrow or peripheral blood of rats | |
KR20130133612A (ko) | PRP(Platelet-Rich Plasma)를 유효성분으로 포함하는 세포 부착능 및 귀소능 증진용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/12/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/08/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 17A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2681 DE 24-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |